Avita Medical management attends Morgan Stanley Global Healthcare Conference fireside chatPUBT·2 hours agoRCEL+6.85%MS+0.37%
Avita Medical PermeaDerm Study Shows 70% Cost Reduction vs. AllograftMarket Beat·Aug 19 at 12:02 PMRCEL+6.85%
AVITA Medical Announces Positive PermeaDerm® Study Results Demonstrating 70% Economic Advantage over Allograft and Comparable Clinical Outcomes | RCEL Stock NewsStockTitan·Aug 18 at 03:45 AMRCEL+6.85%
Avita Medical amends PermeaDerm deal with Stedical, pays USD 500.000 for right to expand exclusive territoryPUBT·Aug 11 at 08:35 PMRCEL+6.85%
U.S. stock night trading opened with fluctuations: Avita Medical fell 4.50% in night trading; AXT Company rose 4.31% in night tradingPrice Alert·Aug 10 at 12:29 AMRCEL+6.85%AXTI+1.50%
AVITA Medical to Host Investor Webinar Briefing | RCEL Stock NewsStockTitan·Aug 9 at 02:00 PMRCEL+6.85%
Biotech and MedTech Sector Signals Divergent Paths Post-EarningsGlobal Report·Aug 9 at 09:12 AMRAIN-3.08%GENB+3.10%
The Biotech Divide of 2026: Commercial Titans vs. AI HopefulsGlobal Report·Aug 8 at 09:21 AMRAIN-3.08%GENB+3.10%
12 Health Care Stocks Moving In Friday's Intraday Sessionbenzinga_article·Aug 7 at 05:05 PMCVRX+0.99%EMBC+8.38%
